Managing Comorbidities, Determinants and Disability at Start and End of TB Treatment under Routine Program Conditions in China.
Yuhong LiuYan LinYuxian SunPruthu ThekkurChanghao ChengYuecui LiYunzhen ShiJun JiangJiong LiaoChuangui NieWenyan SunChengyuan LiangXiaojuan ZhangSang LiuYan MaSelma Dar BergerSrinath SatyanarayanaAjay M V KumarMohammed KhogaliRony ZachariahJonathan E GolubLiang LiAnthony David HarriesPublished in: Tropical medicine and infectious disease (2023)
Many patients with tuberculosis (TB) have comorbidities, risk determinants and disability that co-exist at diagnosis, during and after TB treatment. We conducted an observational cohort study in 11 health facilities in China to assess under routine program conditions (i) the burden of these problems at the start and end of TB treatment and (ii) whether referral mechanisms for further care were functional. There were 603 patients registered with drug-susceptible TB who started TB treatment: 84% were symptomatic, 14% had diabetes, 14% had high blood pressure, 19% smoked cigarettes, 10% drank excess alcohol and in 45% the 6 min walking test (6MWT) was abnormal. Five patients were identified with mental health disorders. There were 586 (97%) patients who successfully completed TB treatment six months later. Of these, 18% were still symptomatic, 12% had diabetes (the remainder with diabetes failed to complete treatment), 5% had high blood pressure, 5% smoked cigarettes, 1% drank excess alcohol and 25% had an abnormal 6MWT. Referral mechanisms for the care of comorbidities and determinants worked well except for mental health and pulmonary rehabilitation for disability. There is need for more programmatic-related studies in other countries to build the evidence base for care of TB-related conditions and disability.
Keyphrases
- mental health
- mycobacterium tuberculosis
- blood pressure
- healthcare
- end stage renal disease
- type diabetes
- cardiovascular disease
- quality improvement
- multiple sclerosis
- chronic kidney disease
- public health
- emergency department
- pulmonary hypertension
- risk assessment
- prognostic factors
- glycemic control
- blood glucose
- hypertensive patients
- adipose tissue
- insulin resistance
- pulmonary tuberculosis
- human health
- antiretroviral therapy